Additionally, MMP-9 is closely associated with tumor invasion and metastasis in a variety of human tumors, including lung adenocarcinoma, hepatocellular carcinoma, and prostate and breast cancers (23–26); furthermore, it was expressed in the serum and urine of patients with RCC (27). Here, MMP9 is linked to breast carcinoma.